Garen G. Bohlin - 12 Sep 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Garen Bohlin
Issuer symbol
KPTI
Transactions as of
12 Sep 2023
Net transactions value
+$49,985
Form type
4
Filing time
12 Sep 2023, 16:07:40 UTC
Previous filing
25 May 2023
Next filing
16 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Purchase $49,985 +41,140 +1028% $1.22 45,140 12 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.1935 to $1.24, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price..